whitepaper
eBook: From ELISA to epigenetics with HTRF
Overcome HTRF detection challenges with optimised microplate reader settings and simplified analysis.
List view / Grid view
Informatics
Filter the results
news
Interactive 3D model of SARS-CoV-2 surface released
A new interactive map of the surface of SARS-CoV-2, featuring the Spike, Envelope and Membrane proteins, has been released for researchers to use.
webinar
Next generation strategies for cancer immunotherapy
24 September 2020 | By PerkinElmer
.Join us on 12 November for our live webinar where two leading researchers will discuss their innovative approaches to developing novel opportunities for immunotherapy treatments.
whitepaper
eBook: The Axon Guide
Electrophysiology and Biophysics Laboratory Techniques Guide from Molecular Devices.
whitepaper
eBook: Software compliance for GMP/GLP labs
Achieve FDA 21 CFR Part 11 compliance with SoftMax® Pro GxP Software.
whitepaper
Article: Imaging dataset for COVID-19 research
Molecular Devices helps Recursion produce the largest publicly available set of human cellular morphological data for COVID-19 therapeutic research.
whitepaper
Interactive demo: Test drive the ImageXpress Pico Automated Cell Imaging System
A powerful, yet affordable, high-content imaging system in your own lab.
news
Stem cells used to identify potential treatments for Parkinson’s disease
Scientists have found two active substances that allowed cells to reactivate the production of a protein that prevents the onset of Parkinson's disease.
news
Tool to track SARS-CoV-2 mutations could inform drug development
A new tool called COVID-3D that monitors SARS-CoV-2 genome mutations could aid drug and vaccine development, its creators say.
news
Genetic analysis reveals disease-causing protein drug targets
An analysis of blood protein levels has supported drug target prioritisation by identifying the causal effects of proteins on diseases, a team has shown.
article
Drug Target Review – Issue 3 2020
This issue includes articles that explore how a next-generation genomics platform can be used for COVID-19 research, the elimination of neutralising AAV antibodies for gene therapies and a new quick and cost-effective biomarker technology for cancer diagnostics. Also in this issue are features on antibody therapeutics for COVID-19 and targets…
news
AI holds promise to accelerate drug repurposing for COVID-19
According to a new report, artificial intelligence (AI) is vital for the rapid identification of drugs that can be repurposed to combat COVID-19.
news
Researchers identify over 550 cancer-driving genes
Computational analysis has been used by researchers to examine 66 types of cancer and identify 568 genes that drive tumour development.
whitepaper
Application note: Improving High Throughput AlphaLISA® with The TEMPEST®
Using TEMPEST®, St. Jude Children’s Research Hospital were able to rapidly screen a focused compound library for early cancer drug candidates in an AlphaLISA® assay.
news
Researchers identify protein that may help SARS-CoV-2 spread through cells
Researchers have found that the SARS-CoV-2 nucleocapsid protein may help the virus to spread from cell to cell, providing a drug target.